Newron Pharmaceuticals S.p.A. Stock
Stocks
NWRN
IT0004147952
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Swiss Exchange
11:31:44 2026-08-31 EDT
|
5-day change | 1st Jan Change | ||
| 12.34 CHF | -0.16% |
|
+1.15% | -48.26% |
| 07-03 | Newron Pharmaceuticals to Make Changes to Phase 3 Trial of Schizophrenia Treatment | MT |
| 05-05 | Edison Is Not Overly Concerned About a Trial Suspension |  |
| Market Cap | 274M 318M 257M 235M 441M 30.26B 444M 3.05B 1.19B 15.34B 1.19B 1.17B 50.81B | P/E 2026 * |
-9.71x | P/E 2027 * | 35.6x |
|---|---|---|---|---|---|
| Enterprise Value | 313M 363M 293M 268M 503M 34.54B 507M 3.48B 1.35B 17.51B 1.36B 1.33B 57.99B | EV / Sales 2026 * |
28.8x | EV / Sales 2027 * | 6.44x |
| Free-Float |
86.89% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : Newron Pharmaceuticals S.p.A.
| 1 day | -0.40% | ||
| 1 week | +1.15% | ||
| Current month | +5.83% | ||
| 1 month | +5.83% | ||
| 3 months | -5.66% | ||
| 6 months | -33.08% | ||
| Current year | -48.26% |
| 1 week | 12.1 |  | 12.8 |
| 1 month | 11.48 | | 13.44 |
| Current year | 11.24 | | 31.85 |
| 1 year | 8.05 | | 31.85 |
| 3 years | 4.09 | | 31.85 |
| 5 years | 1.01 | | 31.85 |
| 10 years | 0.9 | | 31.85 |
| Manager | Title | Age | Since |
|---|---|---|---|
Stefan Weber
CEO | Chief Executive Officer | 62 | 2012-05-14 |
Roberto Galli
DFI | Director of Finance/CFO | - | 2011-12-31 |
Filippo Moriggia
COO | Chief Operating Officer | - | 2021-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Stefan Weber
BRD | Director/Board Member | 62 | 2012-05-14 |
Gillian Dines
BRD | Director/Board Member | - | 2023-03-31 |
Margarita Chavez
BRD | Director/Board Member | - | 2024-04-16 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/12/26 | Buy | Chief Executive Officer | 2,000 | 0.0096% | ||
| 8/11/26 | Buy | Chief Technology Officer | 582 | 0.0028% | ||
| 8/10/26 | Buy | Chief Technology Officer | 1,418 | 0.0068% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.16% | +1.15% | +41.03% | +125.18% | 318M | |
| -1.23% | -1.91% | +0.98% | +17.94% | 50.47B | |
| -1.11% | -2.84% | +420.04% | +505.15% | 44.56B | |
| -0.21% | +0.37% | +42.15% | +17.32% | 43.08B | |
| -1.95% | -3.33% | +8.29% | +73.25% | 41.7B | |
| -0.94% | -1.77% | +18.34% | +46.84% | 33.21B | |
| -1.11% | -4.20% | +25.49% | +119.78% | 16.77B | |
| +6.10% | +4.40% | - | - | 16.28B | |
| +0.25% | -0.41% | +11.91% | +29.03% | 14.58B | |
| -1.12% | -3.46% | +78.75% | +39.37% | 13.92B | |
| Average | -0.16% | -1.26% | +71.89% | +108.21% | 27.49B | |
| Weighted average by Cap. | -0.57% | -1.05% | +89.89% | +122.93% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 10.84M 12.59M 10.18M 9.29M 17.46M 1.2B 17.58M 121M 46.94M 608M 47.29M 46.26M 2.01B | 44.83M 52.07M 42.09M 38.43M 72.19M 4.95B 72.7M 499M 194M 2.51B 195M 191M 8.32B |
| Net income | -31.17M -36.21M -29.27M -26.72M -50.2M -3.45B -50.56M -347M -135M -1.75B -136M -133M -5.78B | 5.02M 5.83M 4.72M 4.31M 8.09M 555M 8.15M 55.89M 21.75M 281M 21.91M 21.43M 932M |
| Net Debt | 38.68M 44.93M 36.32M 33.16M 62.29M 4.27B 62.73M 430M 167M 2.17B 169M 165M 7.18B | 14.72M 17.09M 13.82M 12.61M 23.7M 1.63B 23.87M 164M 63.71M 825M 64.18M 62.78M 2.73B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-31 | CHF 12.34 | -0.16% | 38,643 |
| 26-08-28 | CHF 12.36 | -1.90% | 30,641 |
| 26-08-27 | CHF 12.60 | +3.11% | 49,333 |
| 26-08-26 | CHF 12.22 | -2.08% | 26,028 |
| 26-08-25 | CHF 12.48 | +2.30% | 21,195 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- NWRN Stock
Select your edition
All financial news and data tailored to specific country editions
